Sirona Dx Launches Rapid Saliva Based PCR COVID-19 Testing Service Utilizing Advanced Microfluidics

We have implemented advanced microfluidics technology to enable rapid, accurate, lower cost

COVID-19 testing on easy to collect saliva samples.

The Advanta™ SARS-CoV-2 RT-PCR assay was developed by Fluidigm and is supported by an EUA. The assay is a reverse transcription and real-time polymerase chain reaction (RT-PCR) test that leverages Fluidigm microfluidics technology with the Biomark HD platform.

Test results are available within 24h after arrival at our Portland, OR based clinical laboratory.